Valuation: Cipla Limited

Market Cap 1,162B 12.13B 10.4B 9.73B 8.89B 16.78B 16.96B 115B 44.75B 583B 45.55B 44.56B 1,930B P/E 2027 *
28x
P/E 2028 * 22.6x
Enterprise Value 1,056B 11.02B 9.45B 8.84B 8.08B 15.25B 15.41B 105B 40.66B 530B 41.39B 40.49B 1,754B EV / Sales 2027 *
3.41x
EV / Sales 2028 * 2.97x
Free-Float
68.87%
Yield 2027 *
0.9%
Yield 2028 * 1.02%
1 day+0.40%
1 week-0.83%
Current month-2.40%
1 month+3.22%
3 months+2.77%
6 months+8.40%
Current year-4.86%
1 week 1,408.6
Extreme 1408.6
1,443.6
1 month 1,392.8
Extreme 1392.8
1,491.2
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap.
22/8/24 Sell 2,000 0.0002%
14/8/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%-0.83%-9.73%+16.84% 12.09B
+0.40%-1.04%+16.34%+69.97% 47.71B
+0.12%+1.50%+51.38%+122.20% 40.3B
-1.45%-2.77%+11.63%+71.04% 11.68B
+0.19%+0.58%+30.98%+158.71% 9.19B
+3.49%+2.54%+25.87%+46.08% 7.57B
-0.16%+0.58%+47.14%-11.83% 7.24B
+3.14%+3.12%+23.40%+215.25% 6.84B
-3.24%-9.40%-40.05%+18.52% 5.42B
-1.65%-2.53%+35.68%+102.63% 4.75B
Average +0.09%-1.30%+19.27%+80.94% 15.28B
Weighted average by Cap. +0.21%-0.66%+24.89%+85.60%

Financials

2027 *2028 *
Net sales 310B 3.24B 2.77B 2.59B 2.37B 4.48B 4.52B 30.7B 11.94B 156B 12.15B 11.89B 515B 347B 3.63B 3.11B 2.91B 2.66B 5.02B 5.07B 34.41B 13.38B 174B 13.62B 13.32B 577B
Net income 41.36B 432M 370M 346M 317M 597M 604M 4.1B 1.59B 20.77B 1.62B 1.59B 68.71B 51.42B 537M 460M 430M 394M 743M 751M 5.09B 1.98B 25.82B 2.02B 1.97B 85.42B
Net Debt -106B -1.11B -949M -888M -812M -1.53B -1.55B -10.51B -4.09B -53.26B -4.16B -4.07B -176B -131B -1.37B -1.18B -1.1B -1.01B -1.9B -1.92B -13.02B -5.06B -66B -5.15B -5.04B -218B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
24/08/26 1,437.90 +0.40% 1,220,646
21/08/26 ₹1,432.20 -0.40% 728,275
20/08/26 ₹1,438.00 +1.13% 327,752
19/08/26 ₹1,422.00 -0.64% 433,654
18/08/26 ₹1,431.10 -0.03% 589,396
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,437.90INR
Average target price
1,509.08INR
Spread / Average Target
+4.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock